| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |